Basile Edward M
SEC Form 4 insider trading activity
Basile Edward M has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, Basile Edward M is listed as Director at TransMedics Group, Inc. Inside the rolling window, Basile Edward M reported no open-market purchases and 1 open-market sale totaling $540K in TMDX.
Companies traded
Other insiders at TMDX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$540K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Basile Edward M made?
Basile Edward M has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Basile Edward M trade?
Basile Edward M has filed SEC Form 4 disclosures for 1 company, including TMDX.
When was Basile Edward M's most recent SEC Form 4 filing?
Basile Edward M's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is Basile Edward M's total buy and sell value in the current window?
Inside the rolling retention window, Basile Edward M bought $0 and sold $540K based on SEC Form 4 filings.
What was Basile Edward M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,142 TMDX shares on 2025-10-29, worth $540K, per SEC Form 4 filings.